H

Hospital Universitario | Centro de Investigacion, Prevencion y Tratamiento de Infecciones Respiratorias (CIPTIR)

Research site

(Unclaimed)

Location

Avenue Fco. I. Madero y Gonzalitos, s/n Col. Mitras Centro, Monterrey, Nuevo Leon, Mexico

Site insights

Top conditions

Top treatments

Androgen

Entrectinib

Toremifene Citrate

GLPG0634

Inavolisib

Crizotinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases

The study will compare the efficacy and safety of entrectinib with crizotinib in participants with advanced or metastatic ROS1 non-small cell lung ca...

Enrolling

Carcinoma, Non-Small-Cell Lung

Drug: Entrectinib

Drug: Crizotinib

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer (INAVO122)

This study will evaluate the efficacy and safety of inavolisib in combination with Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for subcuta...

Enrolling

Metastatic Breast Cancer

Drug: Inavolisib

Drug: Optional Endocrine Therapy of Investigator's Choice